Mazumdar Shaw’s Mission to Expand Access to Vital Drugs

Kiran Mazumdar-Shaw founded Biocon in a rented garage nearly 50 years ago, and the company is now among the world's largest insulin producers and a major biosimilar manufacturer. Mazumdar-Shaw discussed her career as a female entrepreneur in India, her work on drug access, and India's approach to artificial intelligence in an interview with Bloomberg's Haslinda Amin. She is transitioning leadership of the multibillion-dollar company to successors.

Next story